BSE filing, NSE: SHREEGANES. Summary written from the filing by ALFA Finder's alert engine.
Shree Ganesh Bio-Tech (India) Ltd: key numbers
- Share price
- ₹0.44
- Market cap
- ₹17.54 Cr
- Revenue (annual)
- ₹4.97 Cr
- Net profit (annual)
- ₹0.38 Cr
- P/E (TTM)
- -45.4×Sector 46.1×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 1.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Bio-Tech (India) Ltd
All →Shree Ganesh Bio-Tech (India) Board Meeting Date
Shree Ganesh Biotech will hold a board meeting on November 2, 2026 for unaudited results. The agenda is proposed and the meeting has not yet occurred.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Biotech (India) Limited held its 16th Annual General Meeting on 28th September 2026, where shareholders adopted financial statements and re-appointed a director.
Shree Ganesh Bio-Tech (India) Annual Report
Shree Ganesh Bio-Tech (India) Limited has released its Annual Report for the financial year 2025-26. The 16th Annual General Meeting is scheduled for September 28, 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Bio-Tech (India) Limited has issued a notice for its 16th Annual General Meeting. The meeting is scheduled for September 28, 2026, at the registered office.
Shree Ganesh Bio-Tech (India) Other Announcement
Shree Ganesh Biotech (India) Limited has updated its official website address to www.shreeganeshbiotech.bar. Exchanges are requested to update their records accordingly.
Shree Ganesh Bio-Tech (India) Other Announcement
Shree Ganesh Biotech (India) Limited has declared that it has no unutilised funds from any prior public issues, rights issues, or preferential placements as of June 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.